Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers

Conditions:   Lung Inflammation;   HIV Seropositivity
Interventions:   Other: ECIGS;   Behavioral: mobile contingency management (mCM);   Other: Usual brand
Sponsors:   Duke University;   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting – verified May 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Evaluation of Tolerability and Safety of “Allergovac Poliplus” in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice

Conditions:   Allergic Rhinitis;   Rhinoconjunctivitis;   Asthma
Intervention:   Biological: Allergovac Poliplus
Sponsor:   BIAL Industrial Farmacéutica S.A.
Not yet recruiting – verified July 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)

Condition:   Hypereosinophilic Syndrome
Interventions:   Drug: Mepolizumab 300 mg;   Drug: Placebo matching mepolizumab;   Drug: Active OCS capsules (5 mg prednisolone or prednisone);   Drug: Placebo matching OCS capsules
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified July 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease

Conditions:   Chronic Obstructive Pulmonary Disease;   Bronchial Asthma;   Interstitial Lung Disease
Interventions:   Device: multiple breath washout test (MBW);   Device: impulse oscillometry (IOS);   Device: body plethysmography (BP);   Device: quantitative computed tomography (qCT)
Sponsor:   Universitätsmedizin Mannheim
Recruiting – verified July 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days